Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 in Treating Subjects With Diabetic Ulcers.

Trial Profile

Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 in Treating Subjects With Diabetic Ulcers.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2012

At a glance

  • Drugs Aclerastide (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors US Biotest Inc
  • Most Recent Events

    • 27 Jun 2012 Full trial results will be published online in the July 2012 issue of Wound Repair and Regeneration, according to a Derma Sciences media release.
    • 27 May 2011 Status changed from active, no longer recruiting to completed.
    • 04 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 May 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top